Skip to main content
DRTS logo

Alpha Tau Medical Ltd.

DRTSNASDAQHealthcareBiotechnology

$12.29Today:- (-)1Y +250.93%

As of Oct 16, 2026 close

Market cap
$1.20B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.43$15.79
Volume (live)
-
Avg. volume (3M)
490.08K

Alpha Tau Medical (DRTS) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Alpha Tau Medical used $26.68M of cash in operating activities and spent $6.08M on capital expenditures. That left free cash flow of −$32.76M.

Alpha Tau Medical Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Alpha Tau Medical Ltd. (DRTS) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-42.63-31.75-29.16-33.76-27.27-8.88-8.46
Depreciation & Amortization2.051.101.800.980.780.090.07
Deferred Income Tax0.000.000.000.000.000.000.99
Stock Based Compensation10.629.927.936.750.810.600.55
Change in Working Capital2.291.172.49-0.310.590.90-0.06
Change in Accounts Payable0.340.971.14-0.992.320.110.15
Change in Other Working Capital-0.070.200.20-1.330.030.79-0.21
Other Operating Activities1.88-0.22-1.10-1.330.030.050.01
Net Cash from Operating Activities-26.68-19.78-17.96-23.88-11.81-7.25-6.91
Investing Activities
Capital Expenditures-6.08-2.24-6.40-0.90-2.93-3.77-1.29
Acquisitions0.000.000.000.000.000.000.01
Purchases of Investments-14.51-125.0828.24-121.14-8.08-4.05-54.27
Sales/Maturities of Investments55.98148.19191.8632.1130.280.0045.40
Other Investing Activities0.00-0.10-3.15-89.0322.20-4.05-0.01
Net Cash from Investing Activities-20.5920.7718.68-89.9419.27-7.82-10.16
Financing Activities
Debt Repayment-5.150.000.000.000.000.000.00
Common Stock Issued45.770.030.0596.910.110.595.25
Other Financing Activities0.000.005.2593.540.000.000.07
Net Cash from Financing Activities45.770.035.3096.910.1129.325.32
Summary
Effect of Forex Changes on Cash-0.020.163.10-0.260.111.93-0.02
Net Change in Cash-1.521.175.97-17.177.5714.33-11.77
Cash at Beginning of Period13.7215.816.6923.8516.170.0013.61
Cash at End of Period12.2016.9815.816.6923.8516.171.84
Free Cash Flow-32.76-22.02-24.36-24.78-14.74-11.02-8.20
Supplemental Disclosures
Interest Paid0.380.320.05----
Income Taxes Paid0.000.010.020.010.000.00-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Alpha Tau Medical Cash Flow

What is Alpha Tau Medical's free cash flow?

Alpha Tau Medical had negative free cash flow of $32.76M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$26.68M minus $6.08M of capital expenditures.

How much does Alpha Tau Medical spend on capital expenditures?

Alpha Tau Medical spent $6.08M on capital expenditures in fiscal 2025, compared with $2.24M a year earlier.

Does Alpha Tau Medical pay dividends or buy back shares?

Alpha Tau Medical's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition